UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Benefit of Oxaliplatin in Stage III Colon Cancer According to IDEA Risk Groups: Findings from the ACCENT Database of 4934 Patients

Clinical colorectal cancer, 2021-06, Vol.20 (2), p.130-136

2021

Volltextzugriff (PDF)

Targeted therapy for metastatic colorectal cancer

Expert review of anticancer therapy, 2018-10, Vol.18 (10), p.991-1006

2018

Volltextzugriff (PDF)

Intergroup Randomized Phase III Study of Postoperative Oxaliplatin, 5‐Fluorouracil, and Leucovorin Versus Oxaliplatin, 5‐Fluorouracil, Leucovorin, and Bevacizumab for Patients with Stage II or III Rectal Cancer Receiving Preoperative Chemoradiation: A Trial of the ECOG‐ACRIN Research Group (E5204)

The oncologist (Dayton, Ohio), 2020-05, Vol.25 (5), p.e798-e807

2020

Volltextzugriff (PDF)

A Phase II Study of Celecoxib With Irinotecan, 5-Fluorouracil, and Leucovorin in Patients With Previously Untreated Advanced or Metastatic Colorectal Cancer

American journal of clinical oncology, 2018-12, Vol.41 (12), p.1193-1198

2018

Volltextzugriff (PDF)

A call for opinions

Gastrointestinal cancer research, 2013-01, Vol.6 (1), p.1-1

Haller, Daniel G

2013

Volltextzugriff (PDF)

The Past and Future of GI Oncology Research

Gastrointestinal cancer research, 2012-09, Vol.5 (5), p.147-148

Haller, Daniel G

2012

Volltextzugriff (PDF)

Keep those cards and letters coming

Gastrointestinal cancer research, 2012-03, Vol.5 (2), p.39-39

Haller, Daniel G

2012

Volltextzugriff (PDF)

Must Reading for GI Oncologists

Gastrointestinal cancer research, 2011-07, Vol.4 (4), p.115-115

Haller, Daniel G

2011

Volltextzugriff (PDF)

Second-line XELOX or FOLFOX-4 for metastatic colorectal cancer

Nature reviews. Clinical oncology, 2009-05, Vol.6 (5), p.250-251

2009

Volltextzugriff (PDF)

What Makes GI Oncology Special?

Gastrointestinal cancer research, 2009-11, Vol.3 (6), p.219-219

Haller, Daniel G

2009

Volltextzugriff (PDF)

Improving Resectability of Hepatic Colorectal Metastases: Expert Consensus Statement By Abdalla et al. Editorial Review

Annals of surgical oncology, 2006-10, Vol.13 (10), p.1281-1283

2006

Volltextzugriff (PDF)

Thoughts on the Coming Year, ISGIO, and the Future of GI Oncology

Gastrointestinal cancer research, 2009-09, Vol.3 (5), p.177-177

Haller, Daniel G

2009

Volltextzugriff (PDF)

In memory of Dr. Henry T. Lynch

Chinese Clinical Oncology, 2019-10, Vol.8 (S1), p.S28-S28

Haller, Daniel G.

2019

Volltextzugriff (PDF)

Long term survival after pancreatic resection for pancreatic adenocarcinoma

The American journal of gastroenterology, 2001, Vol.96 (9), p.2609-2615

2001

Volltextzugriff (PDF)

Accomplishments in gastrointestinal oncology in 2007: conclusion

Gastrointestinal cancer research, 2008-05, Vol.2 (3 Suppl), p.S57-S57

2008

Volltextzugriff (PDF)

Accomplishments in 2007 in the adjuvant treatment of colorectal cancer

Gastrointestinal cancer research, 2008-05, Vol.2 (3 Suppl), p.S2-S6

2008

Volltextzugriff (PDF)

National Clinical Trial Network Gastrointestinal Cancer Trial Mentions in Electronic Physician Resources

Oncology (Williston Park, N.Y.), 2020-11, Vol.34 (11), p.469

2020

Volltextzugriff (PDF)

Providing Protocol Information for Journal of Clinical Oncology Readers: What Practicing Clinicians Need to Know

Journal of clinical oncology, 2011-03, Vol.29 (9), p.1091-1091

2011

Volltextzugriff (PDF)

Entering My Final Year As Editor-in-Chief of Journal of Clinical Oncology

Journal of clinical oncology, 2010-09, Vol.28 (25), p.3901-3901

Haller, Daniel G.

2010

Volltextzugriff (PDF)

The Need for a New Fluoropyrimidine in Advanced Gastric Cancer Treatment

European oncology & haematology, 2012, Vol.8 (4), p.232

2012

Volltextzugriff (PDF)

Using T stage to predict outcomes of adjuvant oxaliplatin (OX)-based chemotherapy (CT) in stage III colon cancer (CC): An ACCENT pooled analysis

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.3606-3606

2022

Volltextzugriff (PDF)

Phase II Trial of Paclitaxel/Cisplatin Followed by Surgery and Adjuvant Radiation Therapy and 5-Fluorouracil/Leucovorin for Gastric Cancer (ECOG E7296)

Gastrointestinal cancer research, 2012-11, Vol.5 (6), p.191-197

2012

Volltextzugriff (PDF)

Clinicopathological and molecular characteristics of early-onset stage III colon adenocarcinoma: An analysis of 25 studies with 35,713 patients in the Adjuvant Colon Cancer End Points (ACCENT) database

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.3597-3597

2021

Volltextzugriff (PDF)

Characteristics of patients (pts) and prognostic factors across treatment lines (TL) in metastatic colorectal cancer (mCRC): An analysis from the Analysis and Research in Cancers of the Digestive System (ARCAD) database

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.3575-3575

2021

Volltextzugriff (PDF)

1 – 25 von 150

Suche als RSS-Feed

Aktive Filter

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(119)
Mit Volltextzugriff
(127)

Publikationsform

Sprache

Englisch
(130)
Deutsch
(19)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Benefit of Oxaliplatin in Stage III Colon Cancer According to IDEA Risk Groups: Findings from the ACCENT Database of 4934 Patients

Targeted therapy for metastatic colorectal cancer

A Phase II Study of Celecoxib With Irinotecan, 5-Fluorouracil, and Leucovorin in Patients With Previously Untreated Advanced or Metastatic Colorectal Cancer

A call for opinions

The Past and Future of GI Oncology Research

Keep those cards and letters coming

Must Reading for GI Oncologists

Second-line XELOX or FOLFOX-4 for metastatic colorectal cancer

What Makes GI Oncology Special?

Improving Resectability of Hepatic Colorectal Metastases: Expert Consensus Statement By Abdalla et al. Editorial Review

Thoughts on the Coming Year, ISGIO, and the Future of GI Oncology

In memory of Dr. Henry T. Lynch

Long term survival after pancreatic resection for pancreatic adenocarcinoma

Accomplishments in gastrointestinal oncology in 2007: conclusion

Accomplishments in 2007 in the adjuvant treatment of colorectal cancer

National Clinical Trial Network Gastrointestinal Cancer Trial Mentions in Electronic Physician Resources

Providing Protocol Information for Journal of Clinical Oncology Readers: What Practicing Clinicians Need to Know

Entering My Final Year As Editor-in-Chief of Journal of Clinical Oncology

The Need for a New Fluoropyrimidine in Advanced Gastric Cancer Treatment

Using T stage to predict outcomes of adjuvant oxaliplatin (OX)-based chemotherapy (CT) in stage III colon cancer (CC): An ACCENT pooled analysis

Phase II Trial of Paclitaxel/Cisplatin Followed by Surgery and Adjuvant Radiation Therapy and 5-Fluorouracil/Leucovorin for Gastric Cancer (ECOG E7296)

Prognostic impact of early treatment discontinuation and early oxaliplatin discontinuation in patients treated with 6 months of oxaliplatin-based adjuvant chemotherapy for stage III colon cancer: an ACCENT/IDEA pooled analysis of 11 trials

Clinicopathological and molecular characteristics of early-onset stage III colon adenocarcinoma: An analysis of 25 studies with 35,713 patients in the Adjuvant Colon Cancer End Points (ACCENT) database

Characteristics of patients (pts) and prognostic factors across treatment lines (TL) in metastatic colorectal cancer (mCRC): An analysis from the Analysis and Research in Cancers of the Digestive System (ARCAD) database

Aktive Filter

Suchergebnisse filtern